We are live on ! Find out more
Primecap Management

Primecap Management Portfolio holdings

AUM $127B
1-Year Est. Return 44.11%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$149B
AUM Growth
+$5.43B
Cap. Flow
-$4.27B
Cap. Flow %
-2.87%
Top 10 Hldgs %
30.32%
Holding
338
New
11
Increased
51
Reduced
229
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 30.47%
2 Healthcare 26.97%
3 Industrials 12.32%
4 Consumer Discretionary 10.96%
5 Financials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVT icon
226
nVent Electric
NVT
$26.7B
$27.7M 0.02%
887,900
LPLA icon
227
LPL Financial
LPLA
$28.6B
$27.5M 0.02%
204,000
SCOR icon
228
Comscore
SCOR
$109M
$27.3M 0.02%
273,352
-1,046
-0.4% -$82K
KEX icon
229
Kirby Corp
KEX
$6.93B
$27.3M 0.02%
450,100
BBIO icon
230
BridgeBio Pharma
BBIO
$16.5B
$27.2M 0.02%
446,860
+91,623
+26% +$5.23M
NUVA
231
DELISTED
NuVasive, Inc.
NUVA
$26.4M 0.02%
388,800
-10,200
-3% -$696K
XMTR icon
232
Xometry
XMTR
$5.34B
$26.2M 0.02%
+300,000
New +$26.2M
ULTA icon
233
Ulta Beauty
ULTA
$24.3B
$26M 0.02%
75,300
MATX icon
234
Matsons
MATX
$6.18B
$25M 0.02%
390,592
-1,700
-0.4% -$111K
NNBR icon
235
NN Inc
NNBR
$311M
$24.8M 0.02%
3,376,100
-1,678,591
-33% -$12.6M
AMH icon
236
American Homes 4 Rent
AMH
$12.5B
$24.6M 0.02%
633,550
-235,650
-27% -$8.74M
GSK icon
237
GSK
GSK
$106B
$22M 0.01%
441,120
-6,320
-1% -$304K
EAT icon
238
Brinker International
EAT
$9.66B
$21.7M 0.01%
+351,200
New +$22.2M
CALA
239
DELISTED
Calithera Biosciences, Inc
CALA
$21.6M 0.01%
517,185
+500
+0.1% +$22K
DOOR
240
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$21.6M 0.01%
193,200
+19,700
+11% +$2.38M
RPD icon
241
Rapid7
RPD
$773M
$19.4M 0.01%
205,400
-1,300
-0.6% -$109K
FOLD
242
DELISTED
Amicus Therapeutics
FOLD
$17.8M 0.01%
1,845,000
-285,000
-13% -$2.78M
GH icon
243
Guardant Health
GH
$22.6B
$17.5M 0.01%
140,952
SNAP icon
244
Snap
SNAP
$9.01B
$17.3M 0.01%
253,600
GTM
245
ZoomInfo Technologies
GTM
$1.22B
$16.9M 0.01%
323,839
+4,750
+1% +$223K
DHR icon
246
Danaher
DHR
$144B
$16.6M 0.01%
+69,965
New +$15.5M
PM icon
247
Philip Morris
PM
$295B
$15.4M 0.01%
155,000
SAIC icon
248
Saic
SAIC
$5.35B
$14.7M 0.01%
167,800
WAT icon
249
Waters Corp
WAT
$39.9B
$14.2M 0.01%
40,998
CCJ icon
250
Cameco
CCJ
$42.4B
$14M 0.01%
730,700
-6,000
-0.8% -$113K

Similar funds

Primecap Management's Q2 2021 Portfolio in Review

As of Q2 2021, Primecap Management held 338 positions worth $149B, up 3.8% from $143B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 4.7%. Primecap Management opened 11 new positions and exited 5, leaving the 338-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Primecap Management's largest Q2 2021 buy was Xometry: 300,000 shares worth $26.2M.
  • Primecap Management added most to Splunk Inc in Q2 2021, an estimated $151M increase.
  • Primecap Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $285M.
  • Primecap Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $16.9M.
  • Primecap Management's ten largest holdings make up 30% of its $149B portfolio in Q2 2021.
  • Primecap Management opened 11 new positions and closed 5 in Q2 2021.
  • Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $149B.

Based on Primecap Management's 13F filing for Q2 2021, filed 10 Aug 2021.